← FDA DRUG APPROVALS

FDA ANDA · ANDA076214

SOTALOL HYDROCHLORIDE

Sponsor: APOTEX

APPLICATION
ANDA076214
TYPE
ANDA
ORIGINAL APPROVAL
2003-08-27
LATEST ACTION
2023-09-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 120MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 160MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 80MG · TABLET · ORAL

Approval history

2023-09-11Labeling · Supplement 14 · standardAP
2021-01-27Labeling · Supplement 7 · standardAP
2015-07-01Labeling · Supplement 4 · standardAP
2003-08-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →